These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 15907260)
1. Non-oral formulations of triptans and their use in acute migraine. Dahlöf CG Curr Pain Headache Rep; 2005 Jun; 9(3):206-12. PubMed ID: 15907260 [TBL] [Abstract][Full Text] [Related]
2. Newer formulations of the triptans: advances in migraine management. Gladstone JP; Gawel M Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731 [TBL] [Abstract][Full Text] [Related]
3. The triptan formulations : how to match patients and products. Rapoport AM; Tepper SJ; Bigal ME; Sheftell FD CNS Drugs; 2003; 17(6):431-47. PubMed ID: 12697002 [TBL] [Abstract][Full Text] [Related]
4. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting. Guidotti M; Ravasio R Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772 [TBL] [Abstract][Full Text] [Related]
5. Part I: what do patients really need and want from migraine treatment? Gendolla A Curr Med Res Opin; 2005; 21 Suppl 3():S3-7. PubMed ID: 16083517 [TBL] [Abstract][Full Text] [Related]
6. Patient preference for triptan formulations: a prospective study with zolmitriptan. Dowson A; Bundy M; Salt R; Kilminster S Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519 [TBL] [Abstract][Full Text] [Related]
7. Clinical applications of new therapeutic deliveries in migraine. Dahlöf C Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656 [TBL] [Abstract][Full Text] [Related]
8. Acute migraine treatment with oral triptans and NSAIDs in a managed care population. Ng-Mak DS; Hu XH; Chen YT; Ma L Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177 [TBL] [Abstract][Full Text] [Related]
9. The 5-HT Whealy M; Becker WJ Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644 [TBL] [Abstract][Full Text] [Related]
11. Formulation Approaches of Triptans for Management of Migraine. Kassem AA Curr Drug Deliv; 2016; 13(6):882-98. PubMed ID: 27109335 [TBL] [Abstract][Full Text] [Related]
12. [Triptans--pivotal event in migraine treatment]. Lusić I; Bilić I Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081 [TBL] [Abstract][Full Text] [Related]
13. Sumatriptan: pharmacological basis and clinical results. Dahlöf CG Curr Med Res Opin; 2001; 17 Suppl 1():s35-45. PubMed ID: 12463276 [TBL] [Abstract][Full Text] [Related]
14. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520 [TBL] [Abstract][Full Text] [Related]
20. Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. Dowson AJ; Tepper SJ; Dahlöf C J Headache Pain; 2005 Jun; 6(3):112-20. PubMed ID: 16355291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]